Previous studies demonstrated the relevance of focal lesions (FL) in whole-body magnetic
resonance imaging (wb-MRI) at the initial workup of patients with smoldering multiple …

Abstract In 2014, the International Myeloma Working Group reclassified patients with
smoldering multiple myeloma (SMM) and bone marrow-plasma cell percentage (BMPC%)≥ …

Purpose The aim of International Myeloma Working Group was to develop practical
recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma …

Purpose To provide an overview on smoldering (asymptomatic) multiple myeloma (SMM)
including current diagnostic criteria, predictors of progression, pattern of progression, and …

Several risk scores for disease progression in patients with smoldering multiple myeloma
(SMM) have been proposed; however, all have been developed using single‐center …

The approach to patients with high-risk smoldering multiple myeloma (SMM) varies among
clinicians; while some advocate early intervention, others reserve treatment at progression …

Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multiple
myeloma (MM). Recently, MM was redefined to include biomarkers predicting a high risk of …

Smoldering multiple myeloma (SMM) bridges the gap between monoclonal gammopathy of
undetermined significance (a mostly premalignant disorder) and active multiple myeloma …

Identification of patient sub-groups with smoldering multiple myeloma (SMM) at high risk of
progression to active disease (MM) is an important goal. 18F-FDG PET/CT (positron …

Background Smoldering (asymptomatic) multiple myeloma is an asymptomatic plasma-cell
proliferative disorder associated with a high risk of progression to symptomatic multiple …